Fundraising Fox

Healthtech Late Stage Investors & VC Firms

847 firms in this list, with a median first check of $1M. 197 of them lead rounds. Generated from verified public data and updated continuously.

Concord Health Partners
SummitLate Stage
13 people
DCP Capital
Camana Bay, Grand CaymanGrowth–Late Stage
4 people
Luma Group
BostonSeed–Late Stage
13 people
Pivotal Life Sciences
San FranciscoSeed–Late Stage
13 people
Oval Park Capital
RaleighSeed–Late Stage$500K – $1.5M
3 people
BPEA EQT
Series B–Late Stage$50M – $3B
8 people
Easton Capital
New YorkSeed–Late Stage$10M – $20M
7 people
Eastside Partners
HuntsvilleSeed–Late Stage
10 people
Glisco Partners
Mexico CitySeries B–Late Stage
13 people
Oltre Impact
MilanSeed–Late Stage$2.2M – $8.6M
10 people
QC·VENTURES
ViennaSeed–Late Stage$216K – $4.3M
7 people
Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
9 people
BOLD Longevity
BostonGrowth–Late Stage
9 people
Eurazeo
ParisSeries A–Late Stage
12 people
The Colorado Impact Fund
DenverSeed–Late Stage$500K – $2M
6 people
Ardenton Capital Corporation
VancouverGrowth–Late Stage
11 people
Ballast Point Ventures
TampaGrowth–Late Stage$5M – $15M
14 people
LSP (Life Sciences Partners)
AmsterdamSeries A–Late Stage$10.8M – $64.8M
8 people
Kama Flow
MoscowSeed–Late Stage
2 people
HongShan Capital Group
Hong KongPre-Seed–Late Stage
Kinnevik
StockholmSeed–Late Stage
Pivotal bioVenture Partners
San FranciscoSeed–Late Stage
12 people
Almeda Ventures
Tel AvivSeed–Late Stage
11 people
Fresenius Medical Care Ventures
Bad HomburgSeed–Late Stage
8 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.